Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
FCUS
Pinnacle Focused Opportunities ETF
$27.24
-0.9%
$26.19
$19.52
$38.02
$40.86M-1.4510,406 shs600 shs
INRO
iShares U.S. Industry Rotation Active ETF
$30.32
-0.3%
$29.17
$22.67
$30.42
$29.71M1.496,659 shs1,851 shs
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
$12.29
+0.2%
$2.78
$2.10
$7.00
$29.69M1.07112,188 shs13,046 shs
PSTR
PeakShares Sector Rotation ETF
$28.09
+0.2%
$27.75
$23.41
$30.33
$31.46MN/A6,165 shs950 shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
FCUS
Pinnacle Focused Opportunities ETF
-0.91%-0.73%+2.56%+10.73%+1.04%
INRO
iShares U.S. Industry Rotation Active ETF
-0.30%+0.90%+3.59%+9.10%+18.35%
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
+0.16%+1.41%+3.86%+9.89%+19.53%
PSTR
PeakShares Sector Rotation ETF
-0.19%+0.92%+0.76%+2.65%+7.30%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
FCUS
Pinnacle Focused Opportunities ETF
N/AN/AN/AN/AN/AN/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
N/AN/AN/AN/AN/AN/AN/AN/A
PSTR
PeakShares Sector Rotation ETF
N/AN/AN/AN/AN/AN/AN/AN/A
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
FCUS
Pinnacle Focused Opportunities ETF
2.63
Moderate Buy$27.24N/A
INRO
iShares U.S. Industry Rotation Active ETF
2.80
Moderate Buy$30.32N/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
0.00
N/AN/AN/A
PSTR
PeakShares Sector Rotation ETF
2.74
Moderate Buy$28.09N/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
FCUS
Pinnacle Focused Opportunities ETF
N/AN/AN/AN/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/AN/AN/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
$9.67M3.07N/AN/A$3.11 per share3.95
PSTR
PeakShares Sector Rotation ETF
N/AN/AN/AN/AN/AN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
FCUS
Pinnacle Focused Opportunities ETF
N/AN/A38.49N/AN/AN/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
N/AN/A26.96N/AN/AN/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
-$39.72M-$3.60N/A1,228.88N/A-98.84%-77.30%-37.75%N/A
PSTR
PeakShares Sector Rotation ETF
N/A-$12.56N/AN/AN/AN/AN/AN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
FCUS
Pinnacle Focused Opportunities ETF
$3.2211.82%N/AN/AN/A
INRO
iShares U.S. Industry Rotation Active ETF
$0.200.66%N/AN/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
N/A0.50%N/AN/AN/A
PSTR
PeakShares Sector Rotation ETF
$1.073.81%N/AN/A N/A

Latest FCUS, PSTR, INRO, and KOOL Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
6/23/2025
PSTR
PeakShares Sector Rotation ETF
Quarterly$0.34385.02%6/23/20256/23/20256/30/2025
6/11/2025
INRO
iShares U.S. Industry Rotation Active ETF
Quarterly$0.05840.83%6/16/20256/16/20256/20/2025
(Data available from 1/1/2013 forward)
CompanyEmployeesShares OutstandingFree FloatOptionable
FCUS
Pinnacle Focused Opportunities ETF
N/A1.50 millionN/ANot Optionable
INRO
iShares U.S. Industry Rotation Active ETF
N/A980,000N/AN/A
Cesca Therapeutics Inc stock logo
KOOL
Cesca Therapeutics
532.42 millionN/ANot Optionable
PSTR
PeakShares Sector Rotation ETF
N/A1.12 millionN/AN/A

Recent News About These Companies

(PSTR) Proactive Strategies
How the (PSTR) price action is used to our Advantage
Trading (PSTR) With Integrated Risk Controls
How to Take Advantage of moves in (PSTR)
THIR THOR Index Rotation ETF
QVOY Q3 All-Season Active Rotation ETF

Media Sentiment Over Time

Top Headlines

View All Headlines

Pinnacle Focused Opportunities ETF NYSEARCA:FCUS

$27.24 -0.25 (-0.91%)
Closing price 08/15/2025 04:10 PM Eastern
Extended Trading
$27.23 -0.01 (-0.04%)
As of 08/15/2025 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Pinnacle Focused Opportunities ETF (FCUS) is an exchange-traded fund that is based on the EQM Pinnacle Focused Equity index. The fund is an actively managed fund that toggles between large-cap equities and Treasurys, or a combination of both, based on a proprietary model that identifies positive and negative market signals in the US equity market. FCUS was launched on Dec 29, 2022 and is managed by Pinnacle.

iShares U.S. Industry Rotation Active ETF NASDAQ:INRO

$30.32 -0.09 (-0.30%)
As of 08/15/2025 03:28 PM Eastern

The BlackRock U.S. Industry Rotation ETF (INRO) is an exchange-traded fund that mostly invests in total market equity. The fund seeks to provide long-term capital appreciation through an actively managed portfolio of US equities. The portfolio rotates towards industries that BlackRock believes are best positioned for outperformance INRO was launched on Mar 26, 2024 and is issued by BlackRock.

Cesca Therapeutics stock logo

Cesca Therapeutics NASDAQ:KOOL

Cesca Therapeutics Inc. develops, commercializes, and markets a range of automated technologies and products for cell-based therapeutics in the United States, China, rest of Asia, Europe, and internationally. The company develops automated blood and bone marrow processing systems that enable the separation, processing, and preservation of cell and tissue therapy products. It offers AutoXpress System, a proprietary automated device and companion sterile disposable for concentrating hematopoietic stem cells from cord blood; Point-of-CareXpress System, a proprietary automated device and companion sterile disposable for the isolation and concentration of hematopoietic stem cells from bone marrow; CAR-TXpress System, a suite of multi-component automated system that allows the automated manufacturing, expansion, and storage of cellular therapies for immuno-oncology; BioArchive System, an automated cryogenic device for single-cassette based cryo-storage of biological license applications products; and manual bag sets for use in the processing and cryogenic storage of cord blood. The company is also developing autologous stem cell-based therapies that address medical needs for applications in the vascular, cardiology, and orthopedic markets. In addition, it provides cell manufacturing and banking services. The company was formerly known as ThermoGenesis Corp. and changed its name to Cesca Therapeutics Inc. in February 2014. Cesca Therapeutics Inc. was founded in 1986 and is headquartered in Rancho Cordova, California. Cesca Therapeutics Inc. is a subsidiary of Boyalife (Hong Kong) Limited.

PeakShares Sector Rotation ETF NASDAQ:PSTR

$28.09 +0.07 (+0.24%)
As of 08/15/2025 03:19 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

The Peakshares Sector Rotation ETF (PSTR) is an exchange-traded fund that mostly invests in total market equity. The fund seeks to provide total return by actively managing a narrow portfolio of US equities. The portfolio rotates towards sectors thought to have the greatest potential for outperformance. PSTR was launched on Apr 30, 2024 and is issued by Peak.